IRIS
RUSSO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.194
EU - Europa 1.451
AS - Asia 1.376
SA - Sud America 373
AF - Africa 342
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 6.758
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.115
IT - Italia 610
SG - Singapore 584
CN - Cina 552
BR - Brasile 335
CI - Costa d'Avorio 264
IE - Irlanda 253
DE - Germania 142
KR - Corea 82
FI - Finlandia 79
UA - Ucraina 69
CA - Canada 65
RU - Federazione Russa 57
AT - Austria 45
VN - Vietnam 45
FR - Francia 44
SN - Senegal 41
NL - Olanda 28
GB - Regno Unito 27
CZ - Repubblica Ceca 18
BE - Belgio 16
SE - Svezia 16
BD - Bangladesh 14
NG - Nigeria 14
AU - Australia 13
AR - Argentina 12
TR - Turchia 12
IN - India 10
UZ - Uzbekistan 10
ZA - Sudafrica 10
JP - Giappone 9
PT - Portogallo 9
PK - Pakistan 8
EC - Ecuador 7
CH - Svizzera 6
CO - Colombia 6
ES - Italia 6
IQ - Iraq 6
IR - Iran 6
PL - Polonia 6
VE - Venezuela 6
BG - Bulgaria 5
GR - Grecia 5
KE - Kenya 5
KZ - Kazakistan 5
MX - Messico 5
NZ - Nuova Zelanda 5
AE - Emirati Arabi Uniti 4
HK - Hong Kong 4
HU - Ungheria 4
ID - Indonesia 4
LB - Libano 4
CR - Costa Rica 3
IL - Israele 3
KG - Kirghizistan 3
TN - Tunisia 3
EG - Egitto 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
LT - Lituania 1
NI - Nicaragua 1
OM - Oman 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 6.758
Salva come PNG Salva come JPEG
Città #
Dallas 697
Santa Clara 524
Chandler 435
Singapore 375
Abidjan 264
Dublin 244
Chicago 178
Hefei 167
Catania 165
Houston 109
Boardman 105
Seoul 82
Ashburn 77
Jacksonville 69
Beijing 68
Civitanova Marche 63
Nuremberg 63
Cambridge 61
Lawrence 61
Andover 55
Los Angeles 55
Helsinki 43
Dakar 41
Nanjing 38
Des Moines 34
Lappeenranta 32
Toronto 28
Vienna 28
Bremen 27
Rome 26
Wilmington 23
Munich 22
Pozzallo 19
Dong Ket 18
Falls Church 18
Ottawa 17
São Paulo 17
Brno 16
Columbus 16
Council Bluffs 16
Acireale 15
Brussels 15
The Dalles 15
Abuja 14
Nanchang 14
Shanghai 14
Saint Petersburg 13
Belo Horizonte 11
Rio de Janeiro 11
San Giovanni la Punta 11
Grafing 10
Hanoi 10
Ho Chi Minh City 10
New York 10
Tianjin 10
Mascalucia 9
Naples 9
Seattle 9
Campinas 8
Messina 8
San Mateo 8
Changsha 7
Hebei 7
L'Île-Saint-Denis 7
Padova 7
Salvador 7
San Francisco 7
Tokyo 7
Turin 7
Zhengzhou 7
Amsterdam 6
Curitiba 6
Jiaxing 6
Palermo 6
Porto Alegre 6
Ragusa 6
Bari 5
Bologna 5
Boston 5
Brooklyn 5
Espinho 5
Fortaleza 5
Lanzhou 5
Maceió 5
Manassas 5
Nairobi 5
Redmond 5
Tashkent 5
Warsaw 5
Arcadia 4
Berlin 4
Brasília 4
Cape Town 4
Florence 4
Guarulhos 4
Hong Kong 4
Juiz de Fora 4
Maletto 4
Melbourne 4
Montreal 4
Totale 4.838
Salva come PNG Salva come JPEG
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 265
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 139
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 134
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 128
Computational modelling in melanoma for novel drug discovery 125
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 121
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 120
Agent based modeling of the immune system: NetLogo, a promising framework 116
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 116
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 116
Boosting multiple sclerosis lesion segmentation through attention mechanism 111
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 110
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 108
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 106
In silico clinical trials: concepts and early adoptions 105
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 105
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 103
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 102
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 102
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 99
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 98
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 98
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 92
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 89
Credibility of In Silico Trial Technologies - A Theoretical Framing 88
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 88
Toward computational modelling on immune system function 87
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 86
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 85
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 84
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 83
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 83
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 82
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 80
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 79
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 78
In silico design of recombinant multi-epitope vaccine against influenza A virus 77
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 76
Computational models to predict disease course and treatment response in multiple sclerosis 76
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 76
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 74
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles 73
PETAL: A Python tool for deep analysis of biological pathways 72
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 71
Generation of digital patients for the simulation of tuberculosis with UISS-TB 71
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 70
Introducing scale factor adjustments on agent-based simulations of the immune system 70
Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models 69
Toward a Regulatory Pathway for the Use of in Silico Trials in The Ce Marking of Medical Devices 67
Computational modelling approaches to vaccinology 67
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 67
How can we accelerate COVID-19 vaccine discovery? 67
ODEs approaches in modeling fibrosis. Comment on "Towards a unified approach in the modeling of fibrosis: A review with research perspectives" by Martine Ben Amar and Carlo Bianca 66
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models 65
Computational immunogenetics 65
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers 64
Modeling biology spanning different scales: An open challenge 63
The combination of artificial intelligence and systems biology for intelligent vaccine design 61
Translatability and transferability of in silico models: Context of use switching to predict the effects of environmental chemicals on the immune system 60
Optimization and analisys of vaccination schedules using simulated annealing and agent based models 60
Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective 58
Moving forward through the in silico modeling of multiple sclerosis: Treatment layer implementation and validation 58
Exploiting Stochastic Petri Net formalism to capture the Relapsing Remitting Multiple Sclerosis variability under Daclizumab administration 57
Text mining and word embedding for classification of decision making variables in breast cancer surgery 56
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility 56
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator 55
Modeling PI3K/PDK1/Akt and MAPK Signaling Pathways using Continuous Petri Nets 54
Uncertainty quantification and sensitivity analysis for in silico trial platform: A preliminary application on UISS-MS 54
Modeling and Simulation of anakinra effects on severe COVID19 Patients 53
Possible Contexts of Use for In Silico trials methodologies: a consensus- based review 53
Universal Immune System Simulator Analysis: The Impact of the Variable Approach Technique® on Enhancing Immune Defense Against infectious diseases 52
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform 52
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator 50
Quality by design tools reducing the gap from bench to bedside for nanomedicine 50
Predictive Modelling of Allergic Responses to Chemical Sensitizers: Distinguishing Skin and Respiratory Reactions 49
In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim 47
Computational modeling approach to suggest possible therapeutic interventions in spinal muscular atrophy 47
Pioneering bioinformatics with agent-based modelling: an innovative protocol to accurately forecast skin or respiratory allergic reactions to chemical sensitizers 47
UISS-GPU: Accelerated In-Silico Tuberculosis Vaccine Trials Using FLAME GPU 44
Novel computational strategies for the identification of new therapeutic targets in melanoma and thyroid cancer. 44
Comment on “A decade of thermostatted kinetic theory models for complex active matter living systems” by Carlo Bianca 42
Model Credibility 41
Generation of digital patients for the simulation of tuberculosis with UISS-TB 41
Genetic algorithm application for the prediction of potential SARS-CoV-2 new variant of concern 40
Verification of an agent-based disease model of human Mycobacterium tuberculosis infection 40
Evaluation of word embedding models to extract and predict surgical data in breast cancer 40
Machine Learning techniques application to predict the quality of life degree in breast cancer patients 40
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation dataset 39
Model Development 36
Toward computational modelling on immune system function 35
In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASs 33
Modeling, simulation and prediction of protein structures for the design of oncolytic viruses 29
Unintended Risks of mRNA COVID-19 Vaccines: A UISS Simulation Study on Immune and Organ Health 28
Verify: A toolbox for deterministic verification of computational models 14
null 1
Totale 6.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.973
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 13 75 25 34 3 29 12 19 31
2021/2022479 48 57 4 13 84 9 62 26 35 20 14 107
2022/20231.111 72 81 23 163 98 173 7 178 217 14 39 46
2023/2024816 32 177 42 21 19 126 22 75 8 111 111 72
2024/20252.328 62 307 128 165 462 297 267 65 117 176 137 145
2025/20261.525 282 370 850 23 0 0 0 0 0 0 0 0
Totale 6.993